Related Stories

YourChoice Therapeutics begins first-in-human trial for male birth control pill

Initial preclinical studies showed YCT-529 was 99% effective and 100% reversible with no side effects.

Dr. Gunda Georg Receives Carl Mannich Medal

Walters Lab Involved in Collaborative Research Investigating Reference Compounds for Characterizing Cellular Injury

Findings can be used to decrease the negative impact on drug discovery of compounds that cause non-specific cell injury.